(PR1E) Amundi Index Solutions - - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU1931974262 • Europe Large-Cap Blend Equity

PR1E: European, Stocks, Equities, ETF, Index, Fund

URL: https://first-eagle.amundi.com/ Index: Morningstar DM Eur TME NR EUR

Additional Sources for PR1E ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

PR1E ETF Overview

Market Cap in USD 90m
Category Europe Large-Cap Blend Equity
TER 0.05%
IPO / Inception 2019-01-30

PR1E ETF Ratings

Growth 5y 62.3%
Fundamental -
Dividend 66.7%
Rel. Strength Industry 5.6
Analysts -
Fair Price Momentum 29.73 EUR
Fair Price DCF -

PR1E Dividends

Dividend Yield 12m 2.73%
Yield on Cost 5y 4.03%
Annual Growth 5y 11.03%
Payout Consistency 95.9%

PR1E Growth Ratios

Growth Correlation 3m 54.7%
Growth Correlation 12m 65.6%
Growth Correlation 5y 91.2%
CAGR 5y 8.72%
CAGR/Max DD 5y 0.27
Sharpe Ratio 12m 0.92
Alpha 3.96
Beta 0.45
Volatility 9.33%
Current Volume 9.1k
Average Volume 20d 2.6k
What is the price of PR1E stocks?
As of February 23, 2025, the stock is trading at EUR 30.67 with a total of 9,050 shares traded.
Over the past week, the price has changed by +0.00%, over one month by +4.14%, over three months by +6.22% and over the past year by +14.69%.
Is Amundi Index Solutions - a good stock to buy?
Yes. Based on ValueRay Analyses, Amundi Index Solutions - (XETRA:PR1E) is currently (February 2025) a good stock to buy. It has a ValueRay Growth Rating of 62.29 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PR1E as of February 2025 is 29.73. This means that PR1E is currently overvalued and has a potential downside of -3.06%.
Is PR1E a buy, sell or hold?
Amundi Index Solutions - has no consensus analysts rating.
What are the forecast for PR1E stock price target?
According to ValueRays Forecast Model, PR1E Amundi Index Solutions - will be worth about 34 in February 2026. The stock is currently trading at 30.67. This means that the stock has a potential upside of +10.96%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 34 11%